{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:22:13Z","timestamp":1790886133919,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ijpharm.2006.08.005","type":"journal-article","created":{"date-parts":[[2006,8,13]],"date-time":"2006-08-13T11:06:09Z","timestamp":1155467169000},"page":"152-160","source":"Crossref","is-referenced-by-count":70,"title":["Recrystallization of fluconazole using the supercritical antisolvent (SAS) process"],"prefix":"10.1016","volume":"328","author":[{"given":"Hee Jun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibeum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Soo","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Joo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2006.08.005_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1081\/PDT-120015052","article-title":"Solid-state characterization of fluconazole","volume":"7","author":"Alkhamis","year":"2002","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib2","series-title":"Elements of X-ray Crystallography","author":"Azaroff","year":"1968"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/op990160z","article-title":"Control of the physical form of salmeterol xinofoate","volume":"3","author":"Beach","year":"1999","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0731-7085(02)00053-5","article-title":"Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry-exploring preferred orientation effects","volume":"28","author":"Campbell Roberts","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.10541","article-title":"Preparation and crystal characterization of a polymorph, a monohydrate, and ethyl acetate solvate of the antifungal fluconazole","volume":"93","author":"Caira","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib6","first-page":"311","article-title":"Differential scanning calorimetry: applications in drug development","volume":"2","author":"Clas","year":"1999","journal-title":"PSTT"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib7","first-page":"67","article-title":"Fluconazole","volume":"vol. 27","author":"Dash","year":"2001"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0040-6031(02)00451-3","article-title":"Thermoanalytical study of polymorphic transformation in fluconazole drug","volume":"399","author":"Desai","year":"2003","journal-title":"Therm. Acta"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.powtec.2004.02.007","article-title":"Particle generation for pharmaceutical applications using supercritical fluid technology","volume":"141","author":"Fages","year":"2004","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib10","series-title":"Polymorphism in Pharmaceutical Solids","first-page":"1","article-title":"Theory and origin of polymorphism","author":"Grant","year":"1999"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jps.2600841210","article-title":"Characterization of polymorphic forms of fluconazole using Fourier-transform Raman spectroscopy","volume":"84","author":"Gu","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/jps.2600640805","article-title":"Characterization of habits and crystalline modification of solids and their pharmaceutical applications","volume":"64","author":"Haleblian","year":"1975","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib13","unstructured":"Janos, K., Laszlo, C., Csaba, S., Jenone, F., Ida, D.J., Istivan, H., Eva, W.P., Judit, N.B., Agnes, P., 2001. WO Patent Appl. PCT\/HU01\/00033."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0896-8446(01)00064-X","article-title":"Particle design using supercritical fluids: literature and patent survey","volume":"20","author":"Jung","year":"2001","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1023\/A:1011045729706","article-title":"Polymorph control of sulfathiazole on supercritical CO2","volume":"18","author":"Kordikowski","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib16","unstructured":"Lo, J.B., Mackay, G.G., Puz, M.J., 1994. UK Patent Appl. GB 2270521."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/ie990685f","article-title":"Simulation of the semicontinuous supercritical antisolvent recrystallization process","volume":"39","author":"Lora","year":"2000","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib18","unstructured":"MacSweeney, S., 1999. An examination of the polymorphic and pseudopolymorphic behavior of fluconazole in relation to processing conditions. Ph.D Thesis, Heriot-Watt University, UK."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0939-6411(03)00092-4","article-title":"Study of the solid state of carbamazepine after processing with gas anti-solvent technique","volume":"56","author":"Moneghini","year":"2003","journal-title":"Eur. J. Pharm. Biol."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib20","unstructured":"Physicians\u2019 Desk Reference (PDR), electronic version, 2004. Thomson PDR, Montvale, NJ."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib21","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/S0009-2509(00)00443-7","article-title":"Particle formation by mixing with supercritical antisolvent at high Reynolds numbers","volume":"56","author":"Shekunov","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1023\/A:1011000915769","article-title":"Characterization of two polymorphs of salmeterol xinofoate crystallized from supercritical fluids","volume":"18","author":"Tong","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib23","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1023\/A:1020477204512","article-title":"Supercritical fluids crystallization of budesonide and flunisolide","volume":"19","author":"Velaga","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2005.05.017","article-title":"Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process","volume":"301","author":"Won","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.08.005_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0896-8446(02)00094-3","article-title":"Recrystallization of sulfathiazile and chlorpropamide using the supercritical fluid antisolvent process","volume":"25","author":"Yeo","year":"2003","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.ijpharm.2006.08.005_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.supflu.2003.09.005","article-title":"Crystallization of sulfamethizole using the supercritical and liquid antisolvent processes","volume":"30","author":"Yeo","year":"2004","journal-title":"J. Supercrit. Fluids"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306006545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306006545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T09:52:02Z","timestamp":1547459522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517306006545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0378517306006545"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2006.08.005","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}